VMAT与IMRT在脑转移瘤全脑照射保护海马计划比较

doi:10.3760/cma.j.issn.1004-4221.2018.11.008

Abstract
Figure/Table
References()
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract

Objective To compare the dose distribution between volumetric-modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) in patients with brain metastases receiving hippocampus-sparing whole brain radiotherapy. Methods Forty-six patients with brain metastases admitted to our hospital from 2013 to 2016 were recruited in this study. After fusing the CT and MRI images,the hippocampus was delineated on the fusion images. The three-grade hippocampal avoidance regions were created by using a volumetric expansion of 3,5 and 10 mm surrounding the hippocampus. The planning target volume (PTV) was calculated by subtracting the 5-mm expansion surrounding the hippocampus from the whole brain. The prescription dose was 30 Gy/10 fractions. The 7-field IMRT and single arc VMAT were designed for each case. The dose distribution of PTV,hippocampus and other organs at risk (OARs) were evaluated in both plans. Results The PTV was statistically compared between VMAT and IMRT: V95:95.90% and 94.97%(P=0.000); V90:98.17% and 97.48%(P=0.000);CI:0.825 and 0.813(P=0.013);HI:0.277 and 0.289(P=0.025).The hippocampal dose was also compared between VMAT and IMRT:the Dmax of hippocampus was 1698.9 cGy for VMAT and 1784.9 cGy for IMRT (P=0.002).The Dmean of hippocampus was 1183.8 cGy for VMAT and 1112.7 cGy for IMRT (P=0.000).No statistical significance was observed between IMRT and VMAT in protecting the OARs except the chiasma opticum (3262.6 cGy and 3529.3 cGy,P=0.000).The MU and treatment time of VMAT and IMRT were 651 and 2768(P=0.000),and 188 s and 504 s (P=0.000). Conclusions The dose distribution of PTV in VMAT is significantly better than that in IMRT.VMAT is advantageous in protecting the hippocampus than IMRT.VMAT can significantly shorten treatment time and MU and enhance the equipment utilization. Besides,VMAT can achieve the goal of protecting the hippocampus and meet the prescription dose requirement of PTV.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Gao Han
	Zhai Zhenyu
	Jia Pengfei
	Chen Jian
	Tu Jiali
	Cao Jiajia
	Wu Haijian

Key words： Neoplasms metastasis,brain/whole brain radiotherapy Hippocampus-sparing Neoplasms metastasis,brain/radiotherapy

Received: 06 June 2017

Corresponding Authors: Zhai Zhenyu,Email:1549829033@qq.com

Cite this article:

Gao Han,Zhai Zhenyu,Jia Pengfei et al. Comparison of dose distribution between VMAT and IMRT in patients with brain metastases during hippocampus-sparing whole brain radiotherapy[J]. Chinese Journal of Radiation Oncology, 2018, 27(11): 989-993.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.issn.1004-4221.2018.11.008 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2018/V27/I11/989

[1] Brown PD,Buckner JC,O′Fallon JR,et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination[J].J Clin Oncol,2003,21(13):2519-2524.DOI:10.1200/JCO.2003.04.172.
[2] Gore EM,Bae K,Wong SJ,et al. Phase Ⅲ comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer:Primary analysis of radiation therapy oncology group study RTOG 0214[J].J Clin Oncol,2011,29(3):272-278.DOI:10.1200/JCO.2010.29.1609.
[3] Watson C,Andermann F,Gloor P,et al. Anatomic basis of amygdaloid and hippocampal volume measurement by mangnetic resonance imaging[J].Neurology,1992,42(9):1743-1750.
[4] Tada E,Parent JM,Lowenstein DH,et al. X-radiation causes a prolonged reduction in cell proliferating in the dentate gyrus of adult rates[J].Neuroscience,2000,99:33-41.DOI:10.1016/S0306-4522(00)00151-2.
[5] Gondi V,Pugh SL,Tome WA,et alPreservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933):a phase Ⅱ multi-institutional trial[J].J Clin Oncol,2014,32(34):3810-3816.DOI:10.1200/JCO.2014.57.2909.
[6] Harth S,Abo-Madyan Y,Zheng L,et alEstimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy[J].Radiother Oncol,2013,109(1):152-158.DOI:10/j.radonc.2013.09.009.
[7] Marsh JC,Herskovic AM,Gielda BT,et alIntracranial metastatic disease spares the limbic circuit:a review of 697 metastatic lesions in 107 patients[J].Int J Radiat Oneol Bioi Phys,2010,76(2):504-512.DOI:10/j.ijrobp.2009.02.038.
[8] Wan JF,Zhang SJ,Wang L,et alImplications for preserving neural stem cells in whole brain radiotherapy and prophylactic cranial irradiation:a review of 2270 metastases in 488 patients[J].J Radiat Res,2013,54(2):285-291.DOI:10./jrr/ns085.
[9] 陈远,顾文栋,田野,等.56例NSCLC脑转移灶与海马距离及与海马保护状态下PCI的PTV低剂量区关系[J].中华放射肿瘤学杂志,2016,25(1):42-45.DOI:10.3760/cma.j.issn.1004-4221.2016.01.011.
Chen Y,Gu WD,Tian Y,et al. Relationship between 56 cases of NSCLC brain metastasis and hippocampal distance and low dose of PTV in PCI under the condition of hippocampal protection[J].Cin J Radiat Oncol,2016,25(1):42-45.DOI:10.3760/cma.j.issn.1004-4221.2016.01.011.
[10] Gondi V,Tolakanahalli R,Mehta MP,et alHippocampal-sparing whole-brain radiotherapy:a”How-To” technique using helical Tomotherapy and linear accelerator-based intensity-modulated radiotherapy[J].Int J Radiat Oncol Biol Phys,2010,78(4):1244-1252.DOI:10.1016/j.ijrobp.2010.01.039.
[11] Wang BH,Hua W,Gu X,et al. Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imaging[J].Australas Phys Eng Sci Med,2015,38:767-775.DOI:10.1007/s13246-015-0397-7.
[12] 董昕,周宗玫,苗俊杰等.局限期小细胞肺癌全脑预防照射保护海马回区的初步临床研究[J].中华放射肿瘤学杂志,2015,24(2):131-136.DOI:10.3760/cma.j.issn.10044221.2015.02.007.
[13] Redmond KJ,Mahone EM,Terezakis S,et alAssociation between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsyehological testing in children:a prospective study[J].Neuro Oncol,2013,15(3):360-369.DOI:10.1093/neuonc/nos303.
[14] Gondi V,Hermann BP,Mehta MP,et al. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors[J].Int J Radiat Oncol Biol Phys,2013,85(2):348-354.DOI:10.1016/j.ijrobp.2012.11.031.
[15] Tsai PF,Yang CC,Chuang CC,et al. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy:a prospective study[J].Radiat Oncol,2015,10(253):1-15.DOI:10.1186/s13014-015-0562-x.
[16] Oehlke O,Wucherpfennig D,Fels F,et al. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases:local tumour control and survival[J].Strahlenther Onkol,2015,191(6):461-469.DOI:10.1007/s00066-014-0808-9.